Selected research
Industry Research
Hormonal Supplements Industry Research Report 2026
Market perspective
The global Hormonal Supplements market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hormonal Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hormonal Supplements is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hormonal Supplements is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hormonal Supplements include Novartis AG, Merck & Co., Pfizer Inc., Bayer AG, USANA Health Sciences, Thorne Research, Swanson Health Products, Suntory Holdings and Sisterly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hormonal Supplements market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hormonal Supplements Market by Company
Novartis AG
Merck & Co.
Pfizer Inc.
Bayer AG
USANA Health Sciences
Thorne Research
Swanson Health Products
Suntory Holdings
Sisterly
Nutrascriptives
NOW Foods
Nature's Way
Nature's Bounty Co.
Meiji Holdings Co.
MegaFood
Life Extension
Herbalife Nutrition
GlaxoSmithKline
Garden of Life
Hormonal Supplements Segment by Type
Liquid
Tablets
Chewables
Capsules
Powders
Hormonal Supplements Segment by Application
Online Sales
Offline Sales
Hormonal Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormonal Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hormonal Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormonal Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hormonal Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hormonal Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hormonal Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Tablets
- Chewables
- Capsules
- Powders
Applications
- Online Sales
- Offline Sales
Companies covered
- Novartis AG
- Merck & Co.
- Pfizer Inc.
- Bayer AG
- USANA Health Sciences
- Thorne Research
- Swanson Health Products
- Suntory Holdings
- Sisterly
- Nutrascriptives
- NOW Foods
- Nature's Way
- Nature's Bounty Co.
- Meiji Holdings Co.
- MegaFood
- Life Extension
- Herbalife Nutrition
- GlaxoSmithKline
- Garden of Life
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hormonal Supplements Market Size (2021-2032)
- 2.2.2 Global Hormonal Supplements Sales (2021-2032)
- 2.2.3 Global Hormonal Supplements Market Average Price (2021-2032)
- 2.3 Hormonal Supplements by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Tablets
- 2.3.4 Chewables
- 2.3.5 Capsules
- 2.3.6 Powders
- 2.4 Hormonal Supplements by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hormonal Supplements Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hormonal Supplements Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Hormonal Supplements Revenue of Manufacturers (2021-2026)
- 3.4 Global Hormonal Supplements Average Price by Manufacturers (2021-2026)
- 3.5 Global Hormonal Supplements Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hormonal Supplements, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hormonal Supplements, Product Type & Application
- 3.8 Global Manufacturers of Hormonal Supplements, Established Date
- 3.9 Global Hormonal Supplements Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Hormonal Supplements Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Merck & Co.
- 4.2.1 Merck & Co. Company Information
- 4.2.2 Merck & Co. Business Overview
- 4.2.3 Merck & Co. Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co. Hormonal Supplements Product Portfolio
- 4.2.5 Merck & Co. Recent Developments
- 4.3 Pfizer Inc.
- 4.3.1 Pfizer Inc. Company Information
- 4.3.2 Pfizer Inc. Business Overview
- 4.3.3 Pfizer Inc. Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Inc. Hormonal Supplements Product Portfolio
- 4.3.5 Pfizer Inc. Recent Developments
- 4.4 Bayer AG
- 4.4.1 Bayer AG Company Information
- 4.4.2 Bayer AG Business Overview
- 4.4.3 Bayer AG Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer AG Hormonal Supplements Product Portfolio
- 4.4.5 Bayer AG Recent Developments
- 4.5 USANA Health Sciences
- 4.5.1 USANA Health Sciences Company Information
- 4.5.2 USANA Health Sciences Business Overview
- 4.5.3 USANA Health Sciences Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 USANA Health Sciences Hormonal Supplements Product Portfolio
- 4.5.5 USANA Health Sciences Recent Developments
- 4.6 Thorne Research
- 4.6.1 Thorne Research Company Information
- 4.6.2 Thorne Research Business Overview
- 4.6.3 Thorne Research Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thorne Research Hormonal Supplements Product Portfolio
- 4.6.5 Thorne Research Recent Developments
- 4.7 Swanson Health Products
- 4.7.1 Swanson Health Products Company Information
- 4.7.2 Swanson Health Products Business Overview
- 4.7.3 Swanson Health Products Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Swanson Health Products Hormonal Supplements Product Portfolio
- 4.7.5 Swanson Health Products Recent Developments
- 4.8 Suntory Holdings
- 4.8.1 Suntory Holdings Company Information
- 4.8.2 Suntory Holdings Business Overview
- 4.8.3 Suntory Holdings Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Suntory Holdings Hormonal Supplements Product Portfolio
- 4.8.5 Suntory Holdings Recent Developments
- 4.9 Sisterly
- 4.9.1 Sisterly Company Information
- 4.9.2 Sisterly Business Overview
- 4.9.3 Sisterly Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sisterly Hormonal Supplements Product Portfolio
- 4.9.5 Sisterly Recent Developments
- 4.10 Nutrascriptives
- 4.10.1 Nutrascriptives Company Information
- 4.10.2 Nutrascriptives Business Overview
- 4.10.3 Nutrascriptives Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nutrascriptives Hormonal Supplements Product Portfolio
- 4.10.5 Nutrascriptives Recent Developments
- 4.11 NOW Foods
- 4.11.1 NOW Foods Company Information
- 4.11.2 NOW Foods Business Overview
- 4.11.3 NOW Foods Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 NOW Foods Hormonal Supplements Product Portfolio
- 4.11.5 NOW Foods Recent Developments
- 4.12 Nature's Way
- 4.12.1 Nature's Way Company Information
- 4.12.2 Nature's Way Business Overview
- 4.12.3 Nature's Way Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nature's Way Hormonal Supplements Product Portfolio
- 4.12.5 Nature's Way Recent Developments
- 4.13 Nature's Bounty Co.
- 4.13.1 Nature's Bounty Co. Company Information
- 4.13.2 Nature's Bounty Co. Business Overview
- 4.13.3 Nature's Bounty Co. Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nature's Bounty Co. Hormonal Supplements Product Portfolio
- 4.13.5 Nature's Bounty Co. Recent Developments
- 4.14 Meiji Holdings Co.
- 4.14.1 Meiji Holdings Co. Company Information
- 4.14.2 Meiji Holdings Co. Business Overview
- 4.14.3 Meiji Holdings Co. Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Meiji Holdings Co. Hormonal Supplements Product Portfolio
- 4.14.5 Meiji Holdings Co. Recent Developments
- 4.15 MegaFood
- 4.15.1 MegaFood Company Information
- 4.15.2 MegaFood Business Overview
- 4.15.3 MegaFood Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 MegaFood Hormonal Supplements Product Portfolio
- 4.15.5 MegaFood Recent Developments
- 4.16 Life Extension
- 4.16.1 Life Extension Company Information
- 4.16.2 Life Extension Business Overview
- 4.16.3 Life Extension Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Life Extension Hormonal Supplements Product Portfolio
- 4.16.5 Life Extension Recent Developments
- 4.17 Herbalife Nutrition
- 4.17.1 Herbalife Nutrition Company Information
- 4.17.2 Herbalife Nutrition Business Overview
- 4.17.3 Herbalife Nutrition Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Herbalife Nutrition Hormonal Supplements Product Portfolio
- 4.17.5 Herbalife Nutrition Recent Developments
- 4.18 GlaxoSmithKline
- 4.18.1 GlaxoSmithKline Company Information
- 4.18.2 GlaxoSmithKline Business Overview
- 4.18.3 GlaxoSmithKline Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 GlaxoSmithKline Hormonal Supplements Product Portfolio
- 4.18.5 GlaxoSmithKline Recent Developments
- 4.19 Garden of Life
- 4.19.1 Garden of Life Company Information
- 4.19.2 Garden of Life Business Overview
- 4.19.3 Garden of Life Hormonal Supplements Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Garden of Life Hormonal Supplements Product Portfolio
- 4.19.5 Garden of Life Recent Developments
5 Global Hormonal Supplements Market Scenario by Region
- 5.1 Global Hormonal Supplements Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hormonal Supplements Sales by Region: 2021-2032
- 5.2.1 Global Hormonal Supplements Sales by Region: 2021-2026
- 5.2.2 Global Hormonal Supplements Sales by Region: 2027-2032
- 5.3 Global Hormonal Supplements Revenue by Region: 2021-2032
- 5.3.1 Global Hormonal Supplements Revenue by Region: 2021-2026
- 5.3.2 Global Hormonal Supplements Revenue by Region: 2027-2032
- 5.4 North America Hormonal Supplements Market Facts & Figures by Country
- 5.4.1 North America Hormonal Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hormonal Supplements Sales by Country (2021-2032)
- 5.4.3 North America Hormonal Supplements Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hormonal Supplements Market Facts & Figures by Country
- 5.5.1 Europe Hormonal Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hormonal Supplements Sales by Country (2021-2032)
- 5.5.3 Europe Hormonal Supplements Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hormonal Supplements Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hormonal Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hormonal Supplements Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hormonal Supplements Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hormonal Supplements Market Facts & Figures by Country
- 5.7.1 South America Hormonal Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hormonal Supplements Sales by Country (2021-2032)
- 5.7.3 South America Hormonal Supplements Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hormonal Supplements Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hormonal Supplements Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hormonal Supplements Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hormonal Supplements Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hormonal Supplements Sales by Type (2021-2032)
- 6.1.1 Global Hormonal Supplements Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Hormonal Supplements Sales Market Share by Type (2021-2032)
- 6.2 Global Hormonal Supplements Revenue by Type (2021-2032)
- 6.2.1 Global Hormonal Supplements Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hormonal Supplements Revenue Market Share by Type (2021-2032)
- 6.3 Global Hormonal Supplements Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hormonal Supplements Sales by Application (2021-2032)
- 7.1.1 Global Hormonal Supplements Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Hormonal Supplements Sales Market Share by Application (2021-2032)
- 7.2 Global Hormonal Supplements Revenue by Application (2021-2032)
- 7.2.1 Global Hormonal Supplements Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hormonal Supplements Revenue Market Share by Application (2021-2032)
- 7.3 Global Hormonal Supplements Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hormonal Supplements Value Chain Analysis
- 8.1.1 Hormonal Supplements Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hormonal Supplements Production Mode & Process
- 8.2 Hormonal Supplements Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hormonal Supplements Distributors
- 8.2.3 Hormonal Supplements Customers
9 Global Hormonal Supplements Analyzing Market Dynamics
- 9.1 Hormonal Supplements Industry Trends
- 9.2 Hormonal Supplements Industry Drivers
- 9.3 Hormonal Supplements Industry Opportunities and Challenges
- 9.4 Hormonal Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst